Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib
Danielle M Brander, Anne W BeavenDuke University Medical Center, Durham, NC, USAAbstract: Follicular lymphoma is predominantly managed as a chronic disease, with intermittent chemo/immunotherapy reserved for symptomatic progression. It is considered incurable with conventional treatments, and curren...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-03-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/update-on-treatment-of-follicular-non-hodgkinrsquos-lymphoma-focus-on--a9555 |